CPI-17 (phospho Thr38) Rabbit Polyclonal Antibody

Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38

Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38

Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Description: Rabbit polyclonal to Phospho-CPI-17 (T38).

Description: Rabbit polyclonal to CPI-17.

Description: A polyclonal antibody against Phospho-Ets1 (Thr38). Recognizes Phospho-Ets1 (Thr38) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200

Description: A polyclonal antibody against Phospho-Ets1 (Thr38). Recognizes Phospho-Ets1 (Thr38) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200

Description: A polyclonal antibody for detection of Ets-1 phospho Thr38) from Human, Mouse, Rat. This Ets-1 phospho Thr38) antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Ets-1 around the phosphorylation site of T38

Description: A polyclonal antibody for detection of Ets-1 phospho Thr38) from Human, Mouse, Rat. This Ets-1 phospho Thr38) antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Ets-1 around the phosphorylation site of T38

Description: A polyclonal antibody for detection of Ets-1 phospho Thr38) from Human, Mouse, Rat. This Ets-1 phospho Thr38) antibody is for WB , IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Ets-1 around the phosphorylation site of T38

Description: A Rabbit Polyclonal antibody against Ets-1 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Description: A Rabbit Polyclonal antibody against Ets-1 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Description: Rabbit polyclonal ETS1 antibody (Thr38)

Description: A Monoclonal antibody against Human CPI-17 alpha (N-term). The antibodies are raised in Rabbit and are from clone E305. This antibody is applicable in WB and IHC

Description: Rabbit polyclonal CPI17 alpha antibody (Thr38)

Description: A Rabbit Polyclonal antibody against HMG-17 (phospho Ser29) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

Description: A Rabbit Polyclonal antibody against HMG-17 (phospho Ser29) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

Description: A polyclonal antibody for detection of HMG-17 phospho Ser29) from Human, Mouse, Rat. This HMG-17 phospho Ser29) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HMG-17 around the phosphorylation site of S29

Description: A polyclonal antibody for detection of HMG-17 phospho Ser29) from Human, Mouse, Rat. This HMG-17 phospho Ser29) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HMG-17 around the phosphorylation site of S29

Description: A polyclonal antibody for detection of HMG-17 phospho Ser29) from Human, Mouse, Rat. This HMG-17 phospho Ser29) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HMG-17 around the phosphorylation site of S29

Description: Description of target: This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.;Species reactivity: Human, Mouse;Application: ELISA;Assay info: Assay Type: Qualitative DNA Binding ELISA ;Sensitivity:

Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.

Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.

Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.

Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.

Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.

Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells.

Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier.

Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier.

Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.

Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.

Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).

Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).

Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.

Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.

Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.